Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (4440)	3/20/1998 5:43:00 PM
From: Rocketman	Read Replies (1) \| Respond to of 9719

Surprised that Cetus doesn't get a ring as it got merged into Chiron. Only 49X in 15 years at AMGEN, thought it would be more. Makes me feel better about my 45X at INCY and 125Xplus at Norian (still illiquid though). The one we let get away last year was NASI, 21X in 14 months. Ouch, still regret selling that one for only 2X, totally against my gut feelings. Rman

To: Pseudo Biologist who wrote (4440)	3/20/1998 5:50:00 PM
From: Biomaven	Respond to of 9719

<<Four get rings (Genentech, Immunex, Genetic Systems, and Hybritech>> But only two of those (I think) lived happily ever after. <<Actually, our friend MGI (MOGN) is mentioned among the turtles (known then as "Molecular Genetics"; $100 of its stock in July 83 would be worth $25 when the article went to press).>> Hey, don't you know that if you change your name, your old history doesn't count anymore... Peter